New Antibody-Drug Conjugate Demonstrates Promising Safety and Efficacy in Rare Blood Cancer, ASCO Reports
In a groundbreaking development in the treatment of rare hematologic malignancies, researchers have unveiled promising results for a novel antibody-drug ...
